NYSE : VEEV
Veeva Systems Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 312.96 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 50.67B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 50.67B |
| Enterprise Value | 43.58B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 161.91M |
| Shares Outstanding | 161.91M |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 8.32% |
| Owned by Institutions (%) | 90.60% |
| Float | 148.27M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 51.31 |
| Forward PE | 32.42 |
| PS Ratio | 14.65 |
| Forward PS | 12.98 |
| PB Ratio | 6.82 |
| P/TBV Ratio | 7.36 |
| P/FCF Ratio | 30.92 |
| P/OCF Ratio | 30.42 |
| PEG Ratio | 0.93 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 42.95 |
| EV / Sales | 12.60 |
| EV / EBITDA | 40.53 |
| EV / EBIT | 42.11 |
| EV / FCF | 26.59 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.46 |
| Quick Ratio | 5.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.09 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 14.42% |
| Return on Assets (ROA) | 7.58% |
| Return on Invested Capital (ROIC) | 95.58% |
| Return on Capital Employed (ROCE) | 13.61% |
| Weighted Average Cost of Capital (WACC) | 9.36% |
| Revenue Per Employee | $436,188 |
| Profits Per Employee | $127,998 |
| Employee Count | 7,928 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 312.61M |
| Effective Tax Rate | 23.55% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +9.17% |
| 50-Day Moving Average | 283.86 |
| 200-Day Moving Average | 209.23 |
| Relative Strength Index (RSI) | 60.93 |
| Average Volume (20 Days) | 1,502,155 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.20M |
| Short Previous Month | 4.96M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 2.59 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.46B |
| Gross Profit | 2.59B |
| Operating Income | 1.03B |
| Pretax Income | 1.33B |
| Net Income | 1.01B |
| EBITDA | 1.08B |
| EBIT | 1.03B |
| Earnings Per Share (EPS) | $6.10 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.24B |
| Total Debt | 151.70M |
| Net Cash | 7.09B |
| Net Cash Per Share | $43.80 |
| Equity (Book Value) | 7.43B |
| Book Value Per Share | 45.92 |
| Working Capital | 6.49B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.67B |
| Capital Expenditures | -26.69M |
| Depreciation & Amortization | 40.48M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.64B |
| FCF Per Share | $10.12 |
Margins
| Measure | Value |
|---|
| Gross Margin | 74.96% |
| Operating Margin | 29.93% |
| Pretax Margin | 38.38% |
| Profit Margin | 29.34% |
| EBITDA Margin | 31.10% |
| EBIT Margin | 29.93% |
| FCF Margin | 47.39% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.14% |
| Shareholder Yield | 0.14% |
| Earnings Yield | 1.95% |
| FCF Yield | 3.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $303.52 |
| Price Target Difference | -3.02% |
| Analyst Consensus | Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 13.34% |
| EPS Growth Forecast (3Y) | 12.50% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 15.64 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |